{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T23:45:04Z","timestamp":1785887104056,"version":"3.56.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T00:00:00Z","timestamp":1706659200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","award":["NTUH 201211047RSC"],"award-info":[{"award-number":["NTUH 201211047RSC"]}],"id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.jgar.2024.01.019","type":"journal-article","created":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T02:45:45Z","timestamp":1707187545000},"page":"411-418","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["In vitro antimicrobial susceptibility data of global meropenem-resistant Acinetobacter baumannii isolates causing pneumonia: Data from the Antimicrobial Testing Leadership and Surveillance Program, 2014\u20132021, and re-estimations of susceptibility breakpoints and appropriate dosages of important antibiotics for pneumonia treatment"],"prefix":"10.1016","volume":"36","author":[{"given":"Shun-Chung","family":"Hsueh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Tsung","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Chien","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I-Min","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Chuen","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shio-Shin","family":"Jean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2024.01.019_bib0001","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","author":"Murray","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jgar.2024.01.019_bib0002","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.2147\/IDR.S357344","article-title":"Minocycline susceptibility and tetB gene in carbapenem-resistant Acinetobacter baumannii in Taiwan","volume":"15","author":"Yang","year":"2022","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.jgar.2024.01.019_bib0003","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jmii.2021.07.015","article-title":"Multicenter surveillance of antimicrobial susceptibilities and resistance mechanisms among Enterobacterales species and non-fermenting Gram-negative bacteria from different infection sources in Taiwan from 2016 to 2018","volume":"55","author":"Jean","year":"2022","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jgar.2024.01.019_bib0004","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.ijantimicag.2014.01.032","article-title":"Ceftolozane\/tazobactam activity tested against Gram-negative bacterial isolates from hospitalised patients with pneumonia in US and European medical centres","volume":"43","author":"Farrell","year":"2014","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jgar.2024.01.019_bib0005","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.jfma.2011.07.004","article-title":"Mortality risk factors in patients with Acinetobacter baumannii ventilator: associated pneumonia","volume":"110","author":"Chang","year":"2011","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.jgar.2024.01.019_bib0006","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ijantimicag.2017.10.018","article-title":"Early administration of appropriate antimicrobial agents to improve the outcome of carbapenem-resistant Acinetobacter baumannii complex bacteraemic pneumonia","volume":"51","author":"Park","year":"2018","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jgar.2024.01.019_bib0007","doi-asserted-by":"crossref","first-page":"240","DOI":"10.4103\/ijmr.IJMR_2085_17","article-title":"Molecular characterization & epidemiology of carbapenem-resistant Acinetobacter baumannii collected across India","volume":"149","author":"Vijayakumar","year":"2019","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.jgar.2024.01.019_bib0008","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ijantimicag.2014.01.016","article-title":"Colistin-based treatment for extensively drug-resistant Acinetobacter baumannii pneumonia","volume":"43","author":"Khawcharoenporn","year":"2014","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jgar.2024.01.019_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2021.106328","article-title":"Polymyxins for the treatment of lower respiratory tract infections: lessons learned from the integration of clinical pharmacokinetic studies and clinical outcomes","volume":"57","author":"Almangour","year":"2021","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jgar.2024.01.019_bib0010","series-title":"Performance standards for antimicrobial susceptibility testing","year":"2022"},{"key":"10.1016\/j.jgar.2024.01.019_bib0011","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1007\/s00134-012-2628-7","article-title":"Pharmacokinetics of inhaled colistimethate sodium (CMS) in mechanically ventilated critically ill patients","volume":"38","author":"Athanassa","year":"2012","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jgar.2024.01.019_bib0012","first-page":"e01154","volume":"63","author":"Flamm","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2024.01.019_bib0013","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.jmii.2020.04.017","article-title":"In vitro susceptibility of ceftaroline against clinically important Gram-positive cocci, Haemophilus species and Klebsiella pneumoniae in Taiwan: results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) in 2012-2018","volume":"54","author":"Jean","year":"2021","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jgar.2024.01.019_bib0014","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1128\/JCM.01798-07","article-title":"Application of a microsphere-based array for rapid identification of Acinetobacter spp. with distinct antimicrobial susceptibilities","volume":"46","author":"Lin","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jgar.2024.01.019_bib0015","series-title":"Performance standards for antimicrobial susceptibility testing","year":"2018"},{"key":"10.1016\/j.jgar.2024.01.019_bib0016","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ijid.2019.11.006","article-title":"Antimicrobial activity of cefoperazone-sulbactam tested against Gram-negative organisms from Europe, Asia-Pacific, and Latin America","volume":"91","author":"Sader","year":"2020","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jgar.2024.01.019_bib0017","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/jac\/dky448","article-title":"Minocycline susceptibility breakpoints for Acinetobacter baumannii: do we need to re-evaluate them?","volume":"74","author":"Tsakris","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2024.01.019_bib0018","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.2147\/IDR.S170233","article-title":"Carbapenem-resistant Acinetobacter baumannii and Pseudomonas aeruginosa: characterization of carbapenemase genes and E-test evaluation of colistin-based combinations","volume":"11","author":"Ramadan","year":"2018","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.jgar.2024.01.019_bib0019","doi-asserted-by":"crossref","first-page":"S367","DOI":"10.1093\/cid\/ciu706","article-title":"Update on Acinetobacter species: mechanisms of antimicrobial resistance and contemporary in vitro activity of minocycline and other treatment options","volume":"59","author":"Castanheira","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2024.01.019_bib0020","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1592\/phco.31.9.912","article-title":"Revisiting \"older\" antimicrobials in the era of multidrug resistance","volume":"31","author":"Pogue","year":"2011","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jgar.2024.01.019_bib0021","doi-asserted-by":"crossref","first-page":"e01176","DOI":"10.1128\/AAC.01176-17","article-title":"Contribution of the tetB efflux pump to minocycline susceptibility among carbapenem-resistant Acinetobacter baumannii strains","volume":"61","author":"Wang","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2024.01.019_bib0022","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.628736","article-title":"Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii from Khartoum State, Sudan","volume":"12","author":"Al-Hassan","year":"2021","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jgar.2024.01.019_bib0023","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.apjtm.2015.05.011","article-title":"High prevalence of multidrug-resistance in Acinetobacter baumannii and dissemination of carbapenemase-encoding genes blaOXA-23-like, blaOXA-24-like and blaNDM-1 in Algiers hospitals","volume":"8","author":"Khorsi","year":"2015","journal-title":"Asian Pac J Trop Med"},{"key":"10.1016\/j.jgar.2024.01.019_bib0024","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.02759-21","article-title":"Carbapenem-resistant Acinetobacter baumannii in U.S. hospitals: diversification of circulating lineages and antimicrobial resistance","volume":"13","author":"Iovleva","year":"2022","journal-title":"mBio"},{"key":"10.1016\/j.jgar.2024.01.019_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.106195","article-title":"Genomic and phenotypic characterisation of antimicrobial resistance in carbapenem-resistant Acinetobacter baumannii hyperendemic clones CC1, CC15, CC79 and CC25","volume":"56","author":"Camargo","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jgar.2024.01.019_bib0026","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/jac\/dkl224","article-title":"Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines","volume":"58","author":"Agwuh","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2024.01.019_bib0027","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.ijantimicag.2017.06.026","article-title":"Pharmacodynamics of minocycline against Acinetobacter baumannii studied in a pharmacokinetic model of infection","volume":"50","author":"Alfouzan","year":"2017","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jgar.2024.01.019_bib0028","first-page":"e02371","article-title":"Pharmacokinetics and pharmacodynamics of minocycline against Acinetobacter baumannii in a neutropenic murine pneumonia model","volume":"61","author":"Zhou","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2024.01.019_bib0029","doi-asserted-by":"crossref","first-page":"S388","DOI":"10.1093\/cid\/ciu594","article-title":"Carbapenem-resistance in gram-negative bacilli and intravenous minocycline: an antimicrobial stewardship approach at the Detroit Medical Center","volume":"59","author":"Pogue","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2024.01.019_bib0030","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01452-22","article-title":"Development of modernized Acinetobacter baumannii susceptibility test interpretive criteria for recommended antimicrobial agents using pharmacometric approaches","volume":"67","author":"Lepak","year":"2023","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2024.01.019_bib0031","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1517\/17425255.2011.623126","article-title":"Pharmacokinetic and pharmacodynamic evaluation of tigecycline","volume":"7","author":"Giamarellou","year":"2011","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.jgar.2024.01.019_bib0032","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1093\/jac\/dkp056","article-title":"Pharmacodynamic evaluation of tigecycline against Acinetobacter baumannii in a murine pneumonia model","volume":"63","author":"Koomanachai","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2024.01.019_bib0033","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.1128\/AAC.00065-07","article-title":"Evaluation of tigecycline penetration into colon wall tissue and epithelial lining fluid using a population pharmacokinetic model and Monte Carlo simulation","volume":"51","author":"Rubino","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2024.01.019_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2021.106487","article-title":"Intrapulmonary pharmacokinetics of high doses of tigecycline in patients with ventilator-associated pneumonia","volume":"59","author":"Dimopoulos","year":"2022","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jgar.2024.01.019_bib0035","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/8395268","article-title":"Tigecycline therapy for nosocomial pneumonia due to carbapenem-resistant Gram-negative bacteria in critically ill patients who received inappropriate initial antibiotic treatment: a retrospective case study","volume":"2016","author":"Wu","year":"2016","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.jgar.2024.01.019_bib0036","doi-asserted-by":"crossref","first-page":"798","DOI":"10.3390\/antibiotics11060798","article-title":"Pharmacokinetics and pharmacodynamics of colistin methanesulfonate in healthy Chinese subjects after multi-dose regimen","volume":"11","author":"Fan","year":"2022","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.jgar.2024.01.019_bib0037","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1038\/s41467-022-30635-7","article-title":"Seeking patterns of antibiotic resistance in ATLAS, an open, raw MIC database with patient metadata","volume":"13","author":"Catal\u00e1n","year":"2022","journal-title":"Nat Commun"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716524000249?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716524000249?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:00:50Z","timestamp":1761991250000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716524000249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":37,"alternative-id":["S2213716524000249"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2024.01.019","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro antimicrobial susceptibility data of global meropenem-resistant Acinetobacter baumannii isolates causing pneumonia: Data from the Antimicrobial Testing Leadership and Surveillance Program, 2014\u20132021, and re-estimations of susceptibility breakpoints and appropriate dosages of important antibiotics for pneumonia treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2024.01.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.","name":"copyright","label":"Copyright"}]}}